Clinical trial
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
NCT02918474
Study timeline
Study start (actual)2017-04-28Date precision: day
Registry last updated2026-04-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Anatomic Stage I Breast Cancer AJCC v8unresolved
Anatomic Stage IA Breast Cancer AJCC v8unresolved
Anatomic Stage IB Breast Cancer AJCC v8unresolved
Anatomic Stage II Breast Cancer AJCC v8unresolved
Anatomic Stage IIA Breast Cancer AJCC v8unresolved
Anatomic Stage IIB Breast Cancer AJCC v8unresolved
Anatomic Stage III Breast Cancer AJCC v8unresolved
Ductal Breast Carcinoma In Situunresolved
Invasive Breast Carcinomaunresolved
Prognostic Stage I Breast Cancer AJCC v8unresolved
Sporadic Breast Carcinomaunresolved
Interventions
Decision AidOTHER
Sponsors & collaborators
M.D. Anderson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02918474 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.